Aastrom Biosciences, Inc.Ann Arbor, MI, United States (NASDAQ (CM): ASTM)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Aastrom Biosciences Financial Statements

Aastrom Biosciences Financial Information

Company Type Public
Headquarters
Fiscal Year-End June
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Aastrom Biosciences Income Statement

  2007 2006 2005
Revenue ($ mil.) 0.7 0.9 0.9
Gross Profit ($ mil.) 0.7 0.9 0.8
Operating Income ($ mil.) (19.5) (17.7) (12.4)
Total Net Income ($ mil.) (17.6) (16.5) (11.8)
Diluted EPS (Net Income) (0.15) (0.15) (0.13)
More Aastrom Biosciences financial information

Aastrom Biosciences Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 0.2 0.2 0.1
Gross Profit ($ mil.) 0.1 0.2 --
Operating Income ($ mil.) (5.0) (5.3) (5.5)
Total Net Income ($ mil.) (4.9) (5.1) (5.2)
Diluted EPS (Net Income) (0.04) (0.04) (0.04)
More Aastrom Biosciences financial information

Aastrom Biosciences Stock Quote & Chart

09/05/08 14:58:19 EST • NASDAQ • 0.34 • Increased by +0.0200 • Increased by +6.2500 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Aastrom Biosciences Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 79.04 3.50 1.54
Price/Earnings Ratio -- 15.38 15.76
Price/Book Ratio 1.51 2.94 1.49
Price/Cash Flow Ratio -- 12.49 9.63
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Aastrom Biosciences Financial Ratios

Aastrom Biosciences Competitive Intelligence

Baxter Cytori Therapeutics Johnson & Johnson
Annual Sales ($ mil.) 11,263.0 6.0 61,095.0
Employees 46,000 143 119,200
Market Cap ($ mil.) 42,641.5 176.8 197,008.0

Competitive Landscape